Class II
Terminated
Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd.
Why: Failed Dissolution Specifications
- Company
- Zydus Pharmaceuticals (USA) Inc
Pennington, NJ, United States - Reported
- Dec 23, 2020
- Recall started
- Dec 3, 2020
- Ended
- Dec 20, 2022
- Where sold
- Nationwide
- Amount
- 15,144 cartons
- Full product description
- Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-771-77
- Lots / codes affected
- M915744 OCT 2021 M904770 FEB 2021
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.